Multiple Sclerosis
Conditions
Interventions
Participants will breathe trough the AeonoseTM for 5 minutes.
Sponsors
Drs. M.W.P.M. Lenders
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for patients with MS: - Diagnosis MS confirmed by a neurologist - Age >18 years Inclusion criteria control subjects - Not suspicious of having MS - Age >18 years
Exclusion criteria
Exclusion criteria: - Physically or cognitively being unable to use the Aeonose - Diagnosed with another neurodegenerative or neuroinflammatory disease (besides MS)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigate the accuracy of the AeonoseTM in distinguishing breath prints of patients with various types and stages of MS and sujects without MS, whether it can assist in diagnosing MS, and whether it can monitor its progression. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Improve the model created in the pilot study by expanding the groups. 2.Determine whether eNose patterns differ for various types and stages of MS. 3.Determine whether eNose patterns differ between MS patients with a positive response to medication and MS patients with no response to medication, to predict and monitor the patients response to treatment. 4.Determine whether our eNose models are able to distinguish between subjects who will be diagnosed with MS and those who will not get the diagnosis MS. | — |
Contacts
Public ContactRozemarijn Ettema
Medisch Spectrum Twente
Outcome results
None listed